773869-57-1 Usage
Uses
Used in Organic Synthesis:
3-Hydroxy-4-Iodobenzyl Alcohol is used as a key intermediate in organic synthesis for the production of various organic compounds. Its unique structure allows it to participate in a range of chemical reactions, making it a valuable component in the synthesis of complex organic molecules.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, 3-Hydroxy-4-Iodobenzyl Alcohol is used as a reagent in the synthesis of drugs. Its presence in the synthesis process can contribute to the development of new medications with specific therapeutic properties.
Used in Agrochemical Synthesis:
3-Hydroxy-4-Iodobenzyl Alcohol also finds application in the agrochemical sector, where it is used in the synthesis of various agrochemicals. This includes pesticides, herbicides, and other compounds that are essential for agricultural productivity and crop protection.
Used as a Starting Material:
3-Hydroxy-4-Iodobenzyl Alcohol serves as a starting material for the preparation of other organic compounds. Its versatility in chemical reactions makes it a fundamental component in the creation of a wide array of organic substances for different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 773869-57-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,3,8,6 and 9 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 773869-57:
(8*7)+(7*7)+(6*3)+(5*8)+(4*6)+(3*9)+(2*5)+(1*7)=231
231 % 10 = 1
So 773869-57-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H7IO2/c8-6-2-1-5(4-9)3-7(6)10/h1-3,9-10H,4H2
773869-57-1Relevant articles and documents
BICYCLIC COMPOUND
-
Page/Page column 117, (2011/08/08)
The present invention provides a compound having an ACC inhibitory action, which is useful as an agent for the prophylaxis or treatment of obesity, diabetes, hypertension, hyperlipidemia, cardiac failure, diabetic complications, metabolic syndrome, sarcopenia, cancer and the like, and has superior efficacy. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.